1. Home
  2. BIVI vs MHUA Comparison

BIVI vs MHUA Comparison

Compare BIVI & MHUA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BIVI
  • MHUA
  • Stock Information
  • Founded
  • BIVI 2013
  • MHUA 1990
  • Country
  • BIVI United States
  • MHUA China
  • Employees
  • BIVI N/A
  • MHUA N/A
  • Industry
  • BIVI Biotechnology: Pharmaceutical Preparations
  • MHUA Medical Specialities
  • Sector
  • BIVI Health Care
  • MHUA Health Care
  • Exchange
  • BIVI Nasdaq
  • MHUA Nasdaq
  • Market Cap
  • BIVI 18.6M
  • MHUA 19.6M
  • IPO Year
  • BIVI N/A
  • MHUA 2022
  • Fundamental
  • Price
  • BIVI $1.02
  • MHUA $0.44
  • Analyst Decision
  • BIVI Strong Buy
  • MHUA
  • Analyst Count
  • BIVI 1
  • MHUA 0
  • Target Price
  • BIVI $30.00
  • MHUA N/A
  • AVG Volume (30 Days)
  • BIVI 194.8K
  • MHUA 197.0K
  • Earning Date
  • BIVI 05-12-2025
  • MHUA 04-25-2025
  • Dividend Yield
  • BIVI N/A
  • MHUA N/A
  • EPS Growth
  • BIVI N/A
  • MHUA N/A
  • EPS
  • BIVI N/A
  • MHUA 0.40
  • Revenue
  • BIVI N/A
  • MHUA $96,909,642.00
  • Revenue This Year
  • BIVI N/A
  • MHUA N/A
  • Revenue Next Year
  • BIVI N/A
  • MHUA N/A
  • P/E Ratio
  • BIVI N/A
  • MHUA $1.11
  • Revenue Growth
  • BIVI N/A
  • MHUA N/A
  • 52 Week Low
  • BIVI $0.62
  • MHUA $0.25
  • 52 Week High
  • BIVI $7.50
  • MHUA $1.47
  • Technical
  • Relative Strength Index (RSI)
  • BIVI 47.95
  • MHUA 55.31
  • Support Level
  • BIVI $1.00
  • MHUA $0.41
  • Resistance Level
  • BIVI $1.09
  • MHUA $0.45
  • Average True Range (ATR)
  • BIVI 0.07
  • MHUA 0.05
  • MACD
  • BIVI -0.01
  • MHUA -0.00
  • Stochastic Oscillator
  • BIVI 19.05
  • MHUA 51.07

About BIVI BioVie Inc.

BioVie Inc is a clinical-stage company developing drug therapies to treat chronic debilitating conditions including liver disease and neurological and neuro-degenerative disorders and certain cancers. The Company is conducting a potentially pivotal Phase 3 randomized, double-blind, placebo-controlled, parallel-group, multicenter study to evaluate NE3107 in patients who have mild to moderate Alzheimer's disease. BIV201 has the potential to improve the health of thousands of patients suffering from life-threatening complications of liver cirrhosis due to hepatitis, non-alcoholic steatohepatitis and alcoholism.

About MHUA Meihua International Medical Technologies Co. Ltd.

Meihua International Medical Technologies Co Ltd is engaged in providing disposable medical devices. It serves hospitals, pharmacies, medical institutions, and medical equipment companies. Its product offerings include a Disposable Medical mask, Disposable ID Bracelet, Disposable Artificial Anal bag, Disposable Catheter, and Electonic pump among others.

Share on Social Networks: